PLEASANTON, Calif. -- n6, maker of the icon96™ and icon16 thermocyclers powered by iconPCR™ with AutoNorm intelligent normalization technology for next‑generation sequencing (NGS) library preparation, today announced new and expanded distribution partnerships that significantly increase access to its instruments across Europe, the Middle East, and Africa. With these additions, iconPCR instruments and AutoNorm‑enabled workflows are [...]

CAMBRIDGE, Mass. — Elemental Machines, a pioneer in life sciences operational intelligence, today announced the launch of Resources Manager, its asset intelligence platform, designed to enable life sciences teams to move beyond simple asset monitoring and manage the operational context around their equipment, locations, schedules, and records. Resources is designed to work alongside existing enterprise asset management systems [...]

  We welcome Judy McCaffrey to Malvern Panalytical as the new Global Vice President of Sales and Applications, and member of the company’s Executive Management Team. Judy brings over 20 years of experience in the analytical instruments industry, including more than 14 years in senior leadership roles across EMEAI and North America. In her most [...]

Nature Communications study finds UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods Findings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impact Study defines sequencing, replication and process-control conditions [...]

New York, NY and Walpole, MA – Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today the acquisition of Boston Industries (“Boston Industries” or the “Company”), a Walpole, Massachusetts-based specialist in the technical repair and refurbishment of laboratory instruments. The acquisition adds in-house technical service expertise in flow cytometry, microscopy, liquid handling, and [...]

Latest edition of the Wiley Registry/NIST Mass Spectral Library for leading pharmaceutical, environmental, and forensic laboratories worldwide expands coverage to more than 1.2 million spectra HOBOKEN, NJ — Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today released the new edition of the Wiley Registry/NIST Mass Spectral Library, a reference database that combines two essential [...]

After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue a collaboration with the goal of creating synergies between the parties’ solutions in the field of bioprocess monitoring, ChemoMetec and Roche Diagnostics have today entered a collaboration agreement. The agreement covers the development of a connection kit between the Roche-owned [...]

New 3D Ready™ Cardioid Supplement Kits combine advanced cardiac organoid biology and automated workflows to help researchers generate more reproducible, scalable cardiac models for drug discovery and safety assessment SAN JOSE, Calif., and VIENNA – Molecular Devices, LLC., a Danaher company and a leading provider of high-performance life science solutions, and HeartBeat.bio today announced the upcoming availability of the [...]

Brings 20 years of senior commercial leadership in healthcare and IT, including GE Healthcare and Exact Sciences BILLERICA, Mass. -- Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that seasoned healthcare executive Jim Gute has been appointed Chief Commercial Officer of the company. In this role, he will lead a re-acceleration of [...]

MIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions LEIDEN, The Netherlands -- Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions [...]